Financial Data and Key Metrics Changes - Total revenue surged 568% year over year to $23.6 million in Q3 2025, driven by IMA's 76% quarter-to-quarter growth [9] - Adjusted EBITDA loss improved from $6.5 million in Q1 to $2.1 million in Q3, indicating operational leverage and a clear path to profitability [12][17] - Cash increased to approximately $82 million and Bitcoin holdings valued at around $40 million, resulting in total liquidity of about $120 million with zero debt [7][18] Business Line Data and Key Metrics Changes - IMA achieved $100 million annual recurring revenue (ARR) in the last 11 months, with projections to reach $300 million ARR by the end of 2026 [6] - Subscription rate for IMA stands at 80%, with an average order value increasing by 36% quarter over quarter to $150 [10][11] - Gross margin improved to 60% from 52%, reflecting enhanced profitability [10] Market Data and Key Metrics Changes - International markets now account for 56.5% of total revenue, with the U.S. being the top market followed by Canada, the U.K., Australia, and Singapore [10] - IMA has achieved over 420,000 customer purchases across 31 countries, indicating strong global demand [9] Company Strategy and Development Direction - The company aims to create a new category at the intersection of health and wealth, targeting $1 billion in annual revenue by 2030 [6] - A strategic divestment of non-core assets is underway to focus resources on IMA, the highest margin growth engine [14] - The company is leveraging partnerships with high-profile individuals to enhance brand visibility and credibility [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving $180-$200 million in revenue for 2026, driven by international expansion and new product launches [18] - The company is strategically choosing to scale aggressively rather than prioritize short-term profitability, aiming to capture maximum market share [18] Other Important Information - The company has initiated a Bitcoin accumulation strategy, purchasing one Bitcoin daily since August 1, which is part of a sustainable framework to build shareholder value [8] - The recent $44 million funding round attracted notable investors, enhancing the company's financial position [6] Q&A Session Summary Question: Impressive payback period of 3.9 months - Management explained that the payback period has improved from four to five months at launch to 3.9 months now, indicating marketing efficiencies and strong unit economics [19][20] Question: Strong growth in international markets - Management noted that the U.S. market share has decreased from 70% to 46.5%, with significant growth observed in Canada, Europe, the Middle East, and Southeast Asia [21] Question: Need for additional capital for expansion - Management stated that with current liquidity, there is no expectation of needing new capital for expansion, emphasizing operational flexibility from recent fundraising [22][24]

Core Insights - Prenetics Global Limited's IM8 brand achieved approximately $108 million in annualized recurring revenue (ARR) just 11 months post-launch, marking a significant milestone in its growth trajectory [1][4][9] - The company reported a record monthly revenue of $9 million in October, reflecting a 32% increase from September's $6.8 million, driven by strong subscriber growth and improved retention metrics [4][5] - Prenetics recently completed a $44 million equity offering, which is expected to facilitate accelerated global expansion and enhanced marketing initiatives [3][4] Financial Performance - IM8's monthly revenue reached $9 million in October, representing a 32% month-over-month growth from September [5] - The brand has delivered 13 million servings to over 420,000 customers across 31 countries since its launch [5] - IM8 projects a minimum of $10 million in monthly revenue by December 2025, with total revenues expected to be approximately $60 million for FY 2025 and between $180 million and $200 million for FY 2026 [12] Strategic Initiatives - The recent equity raise positions IM8 for aggressive scaling, including exploring partnerships with elite athletes and global wellness thought leaders [4][5] - The launch of the Daily Ultimate Longevity product has contributed to an increase in average order value from approximately $110 to $145, indicating strong consumer demand [5] - Prenetics aims to continue scaling IM8 through 2026 with initiatives focused on global distribution, product innovations, and retention efforts [8] Market Position - IM8 is recognized as the fastest-growing supplement brand globally, achieving $100 million in ARR within just 11 months of launch, surpassing previous records in the supplements industry [9] - The company is also pioneering in the intersection of health innovation and digital assets, having established a Bitcoin Treasury by purchasing 1 Bitcoin per day, totaling 380 BTC as of November 4, 2025 [10]

Core Insights - Prenetics Global Limited has successfully priced a public offering of approximately $48 million, which includes Class A and Class B warrants, with potential total proceeds of up to $216 million if all warrants are exercised [1][2][12] - The company’s flagship brand, IM8, has achieved $100 million in annual recurring revenue within just 11 months of launch, marking the fastest growth in the supplements industry [4][20] - Prenetics aims to reach $1 billion in annual revenue and $1 billion in Bitcoin holdings within the next five years, supported by a strategic focus on its IM8 brand and Bitcoin treasury initiatives [6][7][15] Financial Overview - The public offering consists of 2,992,596 Class A ordinary shares and warrants, priced at $16.08 per share, with gross proceeds expected to be around $48 million before fees [1][2] - IM8 is projected to generate over $8.6 million in monthly revenue for October 2025, leading to an annual run rate of approximately $103 million [14] - Prenetics will hold approximately $100 million in cash and 275 BTC valued at $31 million as of October 27, 2025, totaling $131 million in liquidity [15][21] Strategic Partnerships - The offering has attracted a distinguished group of investors, including Kraken, American Ventures, and Jihan Wu's GPTX, enhancing Prenetics' strategic value in the cryptocurrency and health sectors [3][5] - Notable investors like Aryna Sabalenka and Adrian Cheng are expected to amplify IM8's global reach and cultural influence [7][20] Market Positioning - Prenetics is positioned at the intersection of health innovation and digital assets, being the first consumer health company to establish a Bitcoin treasury [21] - The company is targeting the $704 billion global supplements market expected by 2030, leveraging its rapid growth and strategic partnerships [4][20]

Core Insights - Prenetics Global Limited has launched Daily Ultimate Longevity, a supplement targeting all 12 hallmarks of aging, reinforcing IM8's rapid growth in the supplement industry [1][3][4] - IM8 has achieved a compound annual growth rate of 2,457%, with monthly revenue increasing from approximately $600,000 to $6.6 million within nine months [1][4] - The global longevity market is projected to reach $314 billion by 2030, positioning IM8 at the forefront of this expanding market [7] Company Overview - Prenetics is a leading consumer health sciences company, with IM8 being one of the fastest-growing supplement brands co-founded by David Beckham [1][11] - The company maintains a strong financial foundation with over $90 million in liquid assets, including approximately $60 million in cash and 255.4 Bitcoin valued at around $31.6 million [10] Product Details - Daily Ultimate Longevity is formulated with IM8's proprietary 5-Complex System, delivering therapeutic doses of clinically-validated ingredients in a powder format [3][5][8] - The product is designed to target key aging pathways such as cellular senescence and mitochondrial dysfunction, supported by human clinical research [5][6][8] - It is priced at $149 for a one-time purchase and $119 per month for subscription, reflecting its premium positioning in the market [9] Market Positioning - The launch of Daily Ultimate Longevity is seen as a category-defining innovation in the rapidly growing longevity market [7][8] - The product's formulation includes high-dose glycine, taurine, and other key ingredients aimed at comprehensive cellular support and energy enhancement [8][12]